Support for Research Excellence Award

Support for Research Excellence Award (R16 — Clinical Trial Not Allowed)

Due Date: 09/29/2025

Launch, sustain, or grow investigator-initiated biomedical research at resource-limited U.S. colleges and universities. The NIH SuRE (R16) program funds independent faculty who are not currently PD/PI on NIH Research Project Grants (except SuRE/SuRE-First), builds campus research capacity, and provides meaningful research experiences for undergraduate and graduate students across NIH mission areas.

Eligibility Criteria:

  • Institutions: U.S. higher-ed awarding BA/BS and/or graduate biomedical degrees; ≤6 million USD/year in NIH RPG total costs in each of the prior two fiscal years; ≥25% Pell-supported undergraduates (IPEDS, either metric, both most-recent years).

  • PD/PI: Single PD/PI only (no MPI); full-time independent faculty at the applicant institution; not PD/PI on active NIH RPGs (R01, R21, R15, R35, U01, etc.); may apply in final year or NCE of SuRE/SuRE-First/SCORE.

  • Project: Biomedical research within NIH mission; clinical trials not allowed; authentic student participation required (include a Student Involvement Plan).

  • Attachments/regs: Two institutional letters (Strategic Plan; PD/PI Support). Required registrations: UEI/SAM, eRA Commons, Grants.gov.

Funding Details:

  • Mechanism: R16 (SuRE).

  • Budget: Up to 100,000 USD direct costs per year (excludes consortium F&A).

  • Project Period: Up to 4 years.

  • Application Types: New, Renewal, Resubmission, Revision.

Deadline:

  • First due date: September 29, 2025 (5:00 PM local).

  • Ongoing NIH standard cycles through 2028 (typically May and September).

Where to Go for Further Information: